Article
A novel defined risk signature based on pyroptosis-related genes can predict the prognosis of prostate cancer
8 Feb 2022
Abstract excerpt
BACKGROUND: Pyroptosis can not only inhibit the occurrence and development of tumors but also develop a microenvironment conducive to cancer growth. However, pyroptosis research in prostate cancer (PCa) has rarely been reported. METHODS: The expression profile and corresponding clinical data were obtained from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases. Patients were divided into...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
